CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.0858
+0.0043 (5.28%)
At close: Oct 31, 2024, 4:00 PM
0.0850
-0.0008 (-0.93%)
After-hours: Oct 31, 2024, 7:54 PM EDT
CERO Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -2.75 | -2.54 | -0.67 | -0.54 |
| Loss (Gain) From Sale of Investments | - | - | - | 0 |
| Other Operating Activities | -5.89 | -0.49 | -2.84 | -0.03 |
| Change in Accounts Payable | 0.64 | 1.88 | 1.64 | 0.02 |
| Change in Income Taxes | -0.58 | -0.58 | 0.6 | - |
| Change in Other Net Operating Assets | 0.48 | 0.2 | 0.17 | -0.65 |
| Operating Cash Flow | -6.63 | -1.52 | -1.09 | -1.2 |
| Other Investing Activities | -7.94 | -7.94 | 180.84 | -306 |
| Investing Cash Flow | -7.94 | -7.94 | 180.84 | -306 |
| Short-Term Debt Issued | - | 0.91 | 0.65 | - |
| Total Debt Issued | 0.71 | 0.91 | 0.65 | 0.09 |
| Total Debt Repaid | -0.17 | - | - | -0.09 |
| Net Debt Issued (Repaid) | 0.54 | 0.91 | 0.65 | - |
| Issuance of Common Stock | 2.73 | - | - | 315.21 |
| Repurchase of Common Stock | -33.48 | -33.48 | -139.35 | - |
| Other Financing Activities | 0.05 | - | - | -6.14 |
| Financing Cash Flow | -23.4 | -32.58 | -138.7 | 309.08 |
| Net Cash Flow | -37.97 | -42.04 | 41.04 | 1.88 |
| Free Cash Flow | -6.63 | -1.52 | -1.09 | -1.2 |
| Free Cash Flow Per Share | -0.73 | -0.23 | -0.05 | -0.12 |
| Levered Free Cash Flow | 14.46 | 5.11 | -13.44 | - |
| Unlevered Free Cash Flow | 14.48 | 5.11 | -13.44 | - |
| Change in Net Working Capital | -17.87 | -6.95 | 11.63 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.